Ukraine Approves Medical Marijuana For Certain Health Conditions, PTSD Left Out For Now

Zinger Key Points
  • Ukraine’s Ministry of Health made public a list of roughly 20 qualifying conditions for which patients can use medical cannabis.
  • The news follows the government's creation of additional rules to regulate the nascent industry earlier this month.
  • The law allowing the distribution of cannabis plants for medical, industrial and scientific purposes in Ukraine went into effect in Aug.

The Ukrainian government green-lighted a list of health conditions that will make patients eligible to use medical marijuana.

The news follows the government’s creation of additional rules to regulate the nascent industry earlier this month, and over a month after a law allowing the distribution of cannabis plants for medical, industrial and scientific purposes in the country went into effect.

Ukraine's President Volodymyr Zelenskyy signed a bill that legalizes medical cannabis law earlier this year after the Ukrainian Parliament successfully unblocked the approval of a medical marijuana legalization bill in January.

Read Also: As Medical Marijuana Becomes Legal In Ukraine, Growing Support Shows Significant Shift In Attitudes

What’s On The List?

Ukraine's Ministry of Health made public a list of roughly 20 qualifying conditions for which patients can get medical cannabis prescribed, such as multiple sclerosis, neuropathy, shingles, cerebral palsy, spinal cord injuries, complications from chemotherapy, childhood epilepsy, Parkinson's disease and weight loss associated with eating disorders. However, post-traumatic stress disorder (PTSD) seems to have been left off the list, at least for now.

The national authority charged with oversight of the entire health system in Ukraine signaled there's a potential for additional conditions to end up on the list going forward.

Zelenskyy and other Ukraine officials previously praised the benefits of cannabis for overall health. The plant has proved useful for citizens helping them to deal with the pain, stress and trauma of the Russo-Ukrainian War that began in 2014. Russia invaded Ukraine in February 2022.

  • Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.

"Taking a medicinal product based on cannabis should be stopped if the desired therapeutic effect is not obtained within 4-12 weeks or in case of serious adverse reactions (including those related to the mental state)," the health ministry said, according to a translation provided by Marijuana Moment. "We remind you that all activities related to medical cannabis will be strictly controlled by the state, and the recreational (non-medical) use of cannabis remains prohibited."

Read Next:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.